NXI Therapeutics
PrivateLast Round
Pre Seed
Jun 18, 2024
Total Funding Raised
$3.95M
Company Overview
NXI Therapeutics operates in Healthcare & Life Sciences and is based in Basel. Its latest recorded funding round was a Pre Seed round in June 2024.
NXI Therapeutics is a biotechnology company that develops a novel class of selective immunosuppressant drugs designed to treat autoimmune diseases and prevent organ transplant rejection.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
NXI Therapeutics Comparables
Compare NXI Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AbolerIS Pharma | 78% | |
| Anokion | 74% | |
| Cour Pharma | 71% |
For institutional investors. Book with your work email.
NXI Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
NXI Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kickfund | Pre Seed |
| JFG Life Sciences Foundation of the University of Basel | Pre Seed |
| BaseLaunch | Pre Seed |
| Venture Kick | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 3, 2025
Monthly visitors increased 87% MoM.
- Dec 21, 2024
Monthly visitors grew 2985% MoM, from 13 to 401.
For institutional investors. Book with your work email.
NXI Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about NXI Therapeutics's valuation, stock price, and market status.
Is NXI Therapeutics a public or private company?
NXI Therapeutics is a private company.
What is the current stock price of NXI Therapeutics?
NXI Therapeutics is a private company, so its shares have no public market price. Caplight tracks NXI Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is NXI Therapeutics worth (valuation)?
Valuation information for NXI Therapeutics is not publicly available.
Can I buy NXI Therapeutics stock?
NXI Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was NXI Therapeutics's last funding round?
NXI Therapeutics's most recent funding round was Pre Seed on June 18, 2024.
Who are the main investors in NXI Therapeutics?
Key investors in NXI Therapeutics include JFG Life Sciences Foundation of the University of Basel.
Will NXI Therapeutics IPO soon?
No public IPO plans have been announced for NXI Therapeutics.
How can I track NXI Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in NXI Therapeutics's shares on secondary markets.